Evotec SE

EVT · Healthcare

About Evotec SE (EVT)

Evotec SE is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.

EVT trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap stock .

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Key Statistics

Current Price
€2.82
Market Cap
€500.74M
52-Week High
€7.17
52-Week Low
€2.41
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

€1,000 Invested in Evotec SE (EVT)

1 Year
€399
+-60%
3 Years
€173
+-83%
5 Years
€67
+-93%
10 Years
€563
+-44%
Since IPO
€158
+-84%

How much would €1,000 invested in EVT be worth today?

What would €1,000 invested in EVT 1 year ago be worth today?

A €1,000 investment in Evotec SE (EVT) in 2025 would be worth €399 as of November 2026, representing a -60.1% total return.

What would €1,000 invested in EVT 3 years ago be worth today?

A €1,000 investment in Evotec SE (EVT) in 2023 would be worth €173 as of November 2026, representing a -82.7% total return.

What would €1,000 invested in EVT 5 years ago be worth today?

A €1,000 investment in Evotec SE (EVT) in 2021 would be worth €67 as of November 2026, representing a -93.3% total return.

What would €1,000 invested in EVT 10 years ago be worth today?

A €1,000 investment in Evotec SE (EVT) in 2016 would be worth €563 as of November 2026, representing a -43.7% total return.

What would €1,000 invested in EVT at IPO be worth today?

A €1,000 investment in Evotec SE (EVT) at IPO would be worth €158 as of November 2026, representing a -84.2% total return.

Monthly Returns Heatmap

Avg Monthly Return
+0.93%
Positive Months
148
46% of 323
Negative Months
174
54% of 323
Data Period
26+ years
323 months
Best Performers
Best month ever: Feb 2000 (+171.2%)
Best month on avg: January (+4.7%)
Worst Performers
Worst month ever: Mar 2000 (-44.2%)
Worst month on avg: July (-2.6%)

Over the past 26+ years (323 months), Evotec SE (EVT) has averaged a monthly return of +0.93% with a median return of -0.88%. The stock had 148 positive months (46%) and 174 negative months (54%). The best month in EVT's history was February 2000 with a +171.2% return, while the worst was March 2000 at -44.2%. Historically, January tends to be the strongest month (averaging +4.7%), and July the weakest (-2.6%).

EVT's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2000 with a cumulative return of +201.5%, and the worst was 2002 at -144.8%.

Annual Returns

Over 27 years of trading history, Evotec SE (EVT) has delivered an average annual return of +14.10% with a median return of +13.47%. The compound annual growth rate (CAGR) is -6.61%. The stock posted gains in 16 years (59%) and losses in 11 years (41%).

EVT's best year was 2003 with a +180.66% gain, while the worst was 2002 at -82.17%. The longest streak of consecutive positive years was 10, and the longest losing streak was 3 years. EVT achieved double-digit gains (10%+) in 15 years. It suffered double-digit losses in 10 years.

Avg Return
+14.10%
Best Year
2003 (+180.66%)
Worst Year
2002 (-82.17%)
Positive Years
16/27
Year Return Start End
2026 -48.29% €5.45 €2.82
2025 -33.50% €8.19 €5.45
2024 -61.49% €21.28 €8.19
2023 +39.45% €15.26 €21.28
2022 -64.09% €42.50 €15.26
2021 +40.36% €30.28 €42.50
2020 +31.37% €23.05 €30.28
2019 +32.74% €17.36 €23.05
2018 +28.63% €13.50 €17.36
2017 +81.40% €7.44 €13.50
2016 +78.47% €4.17 €7.44
2015 +13.47% €3.67 €4.17
2014 +0.27% €3.66 €3.67
2013 +39.57% €2.63 €3.66
2012 +12.37% €2.34 €2.63
2011 -19.97% €2.92 €2.34
2010 +37.09% €2.13 €2.92
2009 +176.62% €0.77 €2.13
2008 -66.95% €2.33 €0.77
2007 -28.31% €3.25 €2.33
2006 +30.00% €2.50 €3.25
2005 -4.38% €2.61 €2.50
2004 -48.23% €5.05 €2.61
2003 +180.66% €1.80 €5.05
2002 -82.17% €10.09 €1.80
2001 -69.52% €33.10 €10.09
2000 +85.00% €17.89 €33.10

Frequently Asked Questions: EVT

What sector is EVT in? ▼

EVT operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.

How has EVT performed historically? ▼

Over 27 years of trading history, EVT has posted gains in 16 years (59% of the time). The best year was 2003 with a +180.7% return. Past performance does not guarantee future results.

How can I invest in EVT? ▼

You can invest in EVT through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold EVT.

Last updated: 11/1/2026